NEWS RELEASE - Pursuant to the February 23, 2012 Memorandum Decision of the United States District Court, the FDA has officially allowed the first qualified green tea health claim as follows: "Green tea may reduce the risk of breast or prostate cancer although the FDA has concluded that there is very little scientific evidence for this claim." For more information see: FDA letter to Sin Hang Lee, MD, posted May 1, 2012
The 710EGCG® tea is the only green tea distinguished from the others by its high EGCG contents for health maintenance. The dry tea leaves contain at least 7.10% EGCG. It is free of pesticide and lead contamination, and is a low fluoride green tea. This green tea standard is set by Sin Hang Lee, MD, based on extensive review of the world’s medical literature.
To maximize the health benefits of drinking green tea, one needs to consume an adequate amount of typical green tea. A typical green tea drink contains 710 µg EGCG/mL, and for a 70 kg (154 lbs) man, the lowest effective dose of typical green tea is 800 mL (26 oz) per day (National Cancer Institute data). Green tea containing 710 µg EGCG/mL is the standard tea used in experimental cancer research. Since typical green tea is customarily brewed at a 1:100 tea leaf-to-water ratio, the dry green tea leaves must have at least 7.10% extractable EGCG. Green teas on the market contain only a fraction of this amount of EGCG.
Frequently ask questions:
1. Why Japanese green tea in the north does not reduce breast cancer risk?
2. What may be harmful elements in tea?
•
www.teaforhealth.com
1-866-DRLEE'STea (375-3378)
Fleminger, Inc. • 160 Hawley Lane, Suite 205 • Trumbull, CT 06611
© 2003-2012. TeaForHealth.
